Analysts Set Smith & Nephew plc (LON:SN) PT at GBX 1,346.20

Shares of Smith & Nephew plc (LON:SN) have received a consensus recommendation of “Moderate Buy” from the six research firms that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is GBX 1,346.20 ($16.91).

Several brokerages have recently issued reports on SN. Royal Bank of Canada reissued an “outperform” rating and issued a GBX 1,500 ($18.84) price target on shares of Smith & Nephew in a report on Friday, April 5th. Barclays restated an “equal weight” rating and set a GBX 1,150 ($14.45) target price on shares of Smith & Nephew in a report on Friday, February 9th. Jefferies Financial Group restated a “buy” rating and set a GBX 1,250 ($15.70) target price on shares of Smith & Nephew in a report on Friday. JPMorgan Chase & Co. boosted their target price on Smith & Nephew from GBX 1,300 ($16.33) to GBX 1,381 ($17.35) and gave the stock an “overweight” rating in a report on Thursday. Finally, Berenberg Bank restated a “buy” rating and set a GBX 1,450 ($18.21) price objective on shares of Smith & Nephew in a research report on Thursday.

Smith & Nephew Price Performance

Shares of SN opened at GBX 996.80 ($12.52) on Friday. The stock has a market cap of £8.72 billion, a P/E ratio of 4,153.33, a price-to-earnings-growth ratio of 0.46 and a beta of 0.51. Smith & Nephew has a 1 year low of GBX 887 ($11.14) and a 1 year high of GBX 1,316.75 ($16.54). The stock’s 50-day moving average price is GBX 1,018.36 and its two-hundred day moving average price is GBX 1,035.73. The company has a current ratio of 1.77, a quick ratio of 0.84 and a debt-to-equity ratio of 59.11.

Smith & Nephew Increases Dividend

The company also recently disclosed a dividend, which will be paid on Wednesday, May 22nd. Shareholders of record on Thursday, March 28th will be paid a dividend of $0.23 per share. This represents a yield of 1.62%. This is an increase from Smith & Nephew’s previous dividend of $0.14. The ex-dividend date of this dividend is Thursday, March 28th. Smith & Nephew’s dividend payout ratio is presently 12,500.00%.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.